Iterum Therapeutics plc (ITRMF) Financials

ITRMF Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 32.5 million 39.9 million
June 30, 2025 34.0 million 37.9 million
March 31, 2025 33.0 million 35.5 million
Dec. 31, 2024 44.6 million 48.7 million

ITRMF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -7.9 million 53000
June 30, 2025 -4.8 million 56000
March 31, 2025 -3.1 million 61000
Dec. 31, 2024 -4.3 million 89000

ITRMF Net Income

No data available :(

ITRMF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 11.0 million 33.5 million -
June 30, 2025 13.0 million 32.4 million -
March 31, 2025 12.7 million 31.9 million -
Dec. 31, 2024 24.1 million 31.1 million -

ITRMF Shares Outstanding

No data available :(

ITRMF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 12571 1.3 million 6.5 million -
June 30, 2025 - 649000 4.2 million -
March 31, 2025 2000 591000 2.8 million -
Dec. 31, 2024 - 1.3 million 2.1 million -

ITRMF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 390000 20000
June 30, 2025 - 696000
March 31, 2025 - 342000
Dec. 31, 2024 - -

ITRMF

Price: $0.04

52 week price:
0.01
1.28

Earnings Per Share: -0.34 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.0 million

Links: